ALECR.PA
Eurofins-Cerep SA [ALECR.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALECR.PA Stock Summary
In the News
ALECR.PA Financial details
Company Rating
-
Market Cap
110.97M
Income
11.53M
Revenue
47.64M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
209
Optionable
No
Shortable
Yes
Earnings
30 Jun 2019
P/E
10.94
Forward P/E
-
PEG
6.4
P/S
2.65
P/B
2.22
P/C
-
P/FCF
39.7
Quick Ratio
1.04
Current Ratio
4.75
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.28K
EPS next Y
-
EPS next Q
-
EPS this Y
17.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
24.46%
Revenue last 5Y
13.35%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
5.1%
SMA50
4.86%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
16%
ROE
23%
ROC
0.2%
Gross Margin
50%
Oper. Margin
24%
Profit Margin
24%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
22200.0-29200.0
52W High
-29.45%
52W Low
-7.21%
RSI
76.23
Rel Volume
-
Avg Volume
-
Volume
Perf Week
0%
Perf Month
5.1%
Perf Quarter
-
Perf Half Y
6.74%
-
-
-
-
Beta
0.581
-
-
Volatility
0%, 481.89%
Prev Close
0%
Price
20600
Change
0%
Company Profile
- Market Capitalization 110.97M
- Employee 209
- CEO Mr. Antoine Duthilleul
- Headquarters Vienne,FR
- IPO Date 2000-04-12
-
Website
https://www.eurofins.fr/cerep 
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.
